Updating Osteoarthritis Treatment Recommendations | Opinion Article

New therapies for osteoarthritis and additional information on the safety and acceptability of existing therapies for patients with the condition have emerged.

FDA Approves Xeljanz for Rheumatoid Arthritis | Opinion Article

The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response

FDA Approves Expanded Indication for Actemra in Rheumatoid Arthritis | Opinion Article

Genentech, Inc., a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for Actemra (tocilizumab) for

FDA Clears EchoSoft Diagnostic Ultrasound Technology | Opinion Article

Echometrix LLC today announced that it has received clearance from the U.S. Food and Drug Administration to market its EchoSoftTM ultrasound technology. EchoSoft is Echometrix’ first commercial

Conference Highlights: ASE 2012 | Conference Coverage

New research was presented at ASE 2012, the American Society of Echocardiography’s 23rd Annual Scientific Sessions, from June 30 to July 3 in Maryland. The features below

New Guidelines on Osteoporosis in Men | Medical Blog

This week, the Endocrine Society issued guidelines on managing osteoporosis in men. Published in the June 1, 2012 issue of Journal of Clinical Endocrinology & Metabolism, the

The Effects of Weight on Disc Degeneration | News Brief

Chinese research indicates that there appears to be a significant association between the presence, extent, and global severity of disc degeneration and BMI. In adults with disc

Rheumatoid Arthritis & Physical Activity | News Brief

Researchers from Chicago have found that too few adult patients with rheumatoid arthritis (RA) appear to be physically active. The study showed that 42% of adults with

The Changing Tide of Knee Arthroscopy in the U.S. | Feature

New research shows that the number of arthroscopic knee procedures increased by nearly 50% between 1996 and 2006, a finding that may have important implications for surgeon workloads and outcomes.

Screening Recommendations for Osteoporosis | Opinion Article

New recommendations for osteoporosis issued by the USPSTF offer major modifications to previous recommendations in 2002, including the addition of validated risk assessment tools to accurately identify potential osteoporosis risk.

Top 10 Drug Markups in the Gray Market | Medical Blog

On average, drugs in short supply are being marked up by 650% on the gray market, according to an analysis released last week by the Premier Healthcare

Most Americans Using Alternative Therapies: Consumer Reports | Medical Blog

A Consumer Reports survey found that while most Americans would choose prescription drugs to treat 12 common conditions, roughly 75% partake in alternative therapies, such as yoga

Guidelines for Managing Patients With Shoulder Arthritis | Feature

The American Academy of Orthopaedic Surgeons has released treatment guidelines for glenohumeral joint osteoarthritis, which contain 16 recommendations— including operative and non-operative treatment options—to assist clinicians in the management of these patients.

An RA Update | Opinion Article

In the June 15, 2008 issue of Arthritis Care & Research, the American College of Rheumatology (ACR) published updated guidelines on the use of nonbiologic disease-modifying anti-rheumatic

Howard Schubiner, MD
Howard Schubiner, MD

Reducing the Pain of Fibromyalgia | Feature

The chronic pain syndrome of fibromyalgia afflicts nearly 2% of women and a smaller proportion of men, and is both enigmatic and controversial. Many patients with fibromyalgia

Conference Highlights: ACR 2010 Annual Scientific Sessions | Conference Coverage

The 2010 Scientific Sessions of the American College of Rheumatology, or ACR, was held from November 7 to 11 in Atlanta. The features below highlight just some

Page 6 of 6« First...23456